What is Regencell Bioscience Holdings Ltd (RGC)?
Regencell Bioscience Holdings Ltd is a biotechnology company engaged in the research, development, and commercialization of regenerative medicine and stem cell therapies. The company focuses on developing treatments aimed at repairing or replacing damaged tissues and organs. Its portfolio includes cellular therapies targeting various medical conditions, with an emphasis on advancing clinical applications through scientific research. Regencell Bioscience Holdings Ltd operates within the broader field of biopharmaceuticals, collaborating with medical institutions and research organizations to explore innovative therapeutic solutions.
Regencell Bioscience Holdings Ltd Stock Price Today: Live Overview
The price today is shaped by active trading, with BitGo Holdings, Inc. currently at $24.59. Throughout the session, it has moved between $24.19 and $25.23, showing a daily change percentage of -2.4145%.
FAQ: Regencell Bioscience Holdings Ltd (RGC)
What is the current price of RGC stock?
The stock is currently priced at $24.59.
Does RGC pay dividends?
Regencell Bioscience Holdings Ltd does not pay dividends.
Does RGC have a formal corporate presence or regional headquarters in the UAE?
Regencell Bioscience Holdings Ltd operates via partners and distributors in the UAE without an official regional presence.
What is RGC best known for?
Regencell Bioscience Holdings Ltd is most famous for its regenerative medicine and stem cell therapies.
What assets are typically shown together with RGC?
Commonly shown alongside RGC: ProShares Short VIX Short-Term Futures ETF, Cromwell Property Group, Unilever PLC - USD
Latest shares articles



